Privia Health Group, Inc. $PRVA Shares Sold by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC cut its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 5.3% during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 52,418 shares of the company’s stock after selling 2,953 shares during the period. Janney Montgomery Scott LLC’s holdings in Privia Health Group were worth $1,206,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of PRVA. CWM LLC lifted its position in Privia Health Group by 50.3% during the 1st quarter. CWM LLC now owns 1,804 shares of the company’s stock worth $40,000 after acquiring an additional 604 shares in the last quarter. Bessemer Group Inc. lifted its position in Privia Health Group by 2,393.4% during the 1st quarter. Bessemer Group Inc. now owns 2,269 shares of the company’s stock worth $51,000 after acquiring an additional 2,178 shares in the last quarter. Russell Investments Group Ltd. lifted its position in Privia Health Group by 2,852.2% during the 1st quarter. Russell Investments Group Ltd. now owns 2,657 shares of the company’s stock worth $60,000 after acquiring an additional 2,567 shares in the last quarter. GAMMA Investing LLC lifted its position in Privia Health Group by 113.1% during the 1st quarter. GAMMA Investing LLC now owns 2,866 shares of the company’s stock worth $64,000 after acquiring an additional 1,521 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd lifted its position in Privia Health Group by 2,115.3% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 3,323 shares of the company’s stock worth $75,000 after acquiring an additional 3,173 shares in the last quarter. 94.48% of the stock is owned by institutional investors and hedge funds.

Privia Health Group Trading Down 0.5%

Shares of NASDAQ PRVA opened at $24.08 on Monday. Privia Health Group, Inc. has a twelve month low of $17.03 and a twelve month high of $26.09. The company has a market capitalization of $2.96 billion, a price-to-earnings ratio of 218.93, a price-to-earnings-growth ratio of 3.28 and a beta of 0.83. The business has a 50 day simple moving average of $22.46 and a 200-day simple moving average of $22.45.

Privia Health Group (NASDAQ:PRVA) last issued its quarterly earnings results on Tuesday, June 7th. The company reported $0.10 earnings per share for the quarter. Privia Health Group had a return on equity of 2.13% and a net margin of 0.78%.The business had revenue of $213.61 million during the quarter. As a group, equities analysts predict that Privia Health Group, Inc. will post 0.14 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts have issued reports on PRVA shares. JMP Securities upped their target price on Privia Health Group from $29.00 to $30.00 and gave the company a “market outperform” rating in a research report on Friday, August 29th. Stephens reaffirmed an “overweight” rating and issued a $32.00 target price on shares of Privia Health Group in a research report on Wednesday, September 24th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Privia Health Group in a research report on Wednesday, October 8th. Barclays upped their target price on Privia Health Group from $21.00 to $22.00 and gave the company an “equal weight” rating in a research report on Thursday. Finally, Zacks Research raised Privia Health Group from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 19th. Eleven equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Privia Health Group currently has a consensus rating of “Moderate Buy” and an average price target of $28.91.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.